Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

16.50 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

6 Analysts Have This to Say About Tandem Diabetes Care ↗

May 05, 2022

Within the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings:

Via Benzinga

57 Stocks Moving In Thursday's Mid-Day Session ↗

May 05, 2022

Gainers

Via Benzinga

Tandem Diabetes' Q1 Bottom-Line Slide Deeper Into Red Despite Sales Growth ↗

May 05, 2022

Via Benzinga

Earnings Scheduled For February 22, 2022 ↗

February 22, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...

Via Benzinga

Recap: Tandem Diabetes Care Q1 Earnings ↗

May 04, 2022

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

May 04, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults

April 27, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022

April 11, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Reports Mixed Q4 Earnings, Issues Better Than Expected FY22 Outlook ↗

February 23, 2022

Tandem Diabetes Care Inc (NASDAQ: TNDM) reported Q4 sales reached $209.9 million, +25% Y/Y, beating the consensus of $199.12 million. The Company posted EPS of $0.16,...

Via Benzinga

Expert Ratings For Tandem Diabetes Care ↗

February 23, 2022

Over the past 3 months, 4 analysts have published their opinion on Tandem Diabetes Care (NASDAQ:TNDM) stock. These analysts are typically employed by large Wall Street banks and...

Via Benzinga

Tandem Diabetes Care: Q4 Earnings Insights ↗

February 22, 2022

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance

February 22, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App

February 16, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

February 11, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2021 Financial Results on February 22, 2022

January 19, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 ↗

January 19, 2022

Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...

Via Benzinga

Stock Market Rallies After Fed Meeting, But Not For Long; Adobe, Rivian, Eli Lilly In Focus: Weekly Review ↗

December 17, 2021

Adobe and Rivian fell on guidance, while Eli Lilly jumped on its raised targets.

Via Investor's Business Daily

46 Biggest Movers From Yesterday ↗

December 16, 2021

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 15, 2021

Gainers Biofrontera (NASDAQ:

Via Benzinga

36 Stocks Moving In Wednesday's Mid-Day Session ↗

December 15, 2021

Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal...

Via Benzinga

Medtronic Hits FDA Snag For Diabetes Business — Leading A Rival To Pop ↗

December 15, 2021

The FDA sent Medtronic a warning letter regarding its diabetes business.

Via Investor's Business Daily

Tandem Diabetes Care Announces Expansion of Senior Leadership Team

December 02, 2021

From Tandem Diabetes Care, Inc.

Via Business Wire

2 Unstoppable Growth Stocks That Could Double Your Money in 5 Years (or Less) ↗

November 20, 2021

These companies have a history of crushing the market.

Via The Motley Fool

Tandem Diabetes Care to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference

November 18, 2021

From Tandem Diabetes Care, Inc.

Via Business Wire

Jim Cramer Shares His Thoughts On Innovative Industrial Properties, Nokia And More ↗

November 10, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Poshmark, Inc. (NASDAQ: POSH) missed the quarter badly when others in that industry are doing quite well,...

Via Benzinga

Why Are Tandem Diabetes Shares Falling Premarket Today? ↗

November 04, 2021

Tandem Diabetes Care Inc (NASDAQ: TNDM) reported Q3 sales of $179.6 million, +45% Y/Y, beating the consensus of $171.41 million. The Company posted EPS of $0.09, a...

Via Benzinga

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Tandem Diabetes Care, inc (TNDM) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

TNDM earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Tandem Diabetes Care: Q3 Earnings Insights ↗

November 03, 2021

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.